PA
CRGX

Perceptive Advisors’s CARGO Therapeutics CRGX Stock Holding History

Perceptive Advisors’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,431,085
Closed -$9.89M – 91
2025
Q1 		$9.89M Sell
2,431,085
-1,251,919
-34% -$8.38M 0.35% 55
2024
Q4 		$53.1M Hold
3,683,004
– – 1.46% 21
2024
Q3 		$68M Hold
3,683,004
– – 1.44% 21
2024
Q2 		$60.5M Buy
3,683,004
+235,000
+7% +$4.47M 1.46% 19
2024
Q1 		$77M Buy
3,448,004
+11,404
+0.3% +$271K 1.35% 25
2023
Q4 		$79.6M Buy
+3,436,600
New +$58.3M 1.78% 14

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return

Perceptive Advisors's CRGX Position: Q2 2025 in Review

Perceptive Advisors sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 2,431,085 shares — an estimated $9.89M sold.

Perceptive Advisors first reported a position in CRGX in Q4 2023 and held it in 6 quarters. The position peaked at $79.6M in Q4 2023. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

  • Perceptive Advisors reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Perceptive Advisors sold 2,431,085 CARGO Therapeutics shares in Q2 2025, an estimated $9.89M.
  • Perceptive Advisors first reported a position in CARGO Therapeutics in Q4 2023 and held it in 6 quarters.
  • Perceptive Advisors's CARGO Therapeutics position peaked at $79.6M in Q4 2023.
  • 116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on Perceptive Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.